Skip to Content

Demant A/S DEMANT

Morningstar Rating
DKK 323.20 +1.60 (0.50%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

DEMANT is trading at a 379% premium.
Price
DKK 321.60
Fair Value
DKK 333.00
Uncertainty
Medium
1-Star Price
DKK 213.00
5-Star Price
DKK 423.00
Economic Moat
Zhnjbd
Capital Allocation
Lxmjzfy

Bulls Say, Bears Say

Bulls

Approximately 16% of the world's population suffers from mild to severe hearing loss, and this is expected to grow to 20% during the next decade. Even in developed countries, hearing aid penetration rates only reach 20% on average.

Bears

The communications segment is struggling in both the gaming and professional lines.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DEMANT is a good fit for your portfolio.

Trading Information

Previous Close Price
DKK 321.60
Day Range
DKK 322.00328.40
52-Week Range
DKK 247.90373.50
Bid/Ask
DKK 322.60 / DKK 323.20
Market Cap
DKK 71.28 Bil
Volume/Avg
357,581 / 279,818

Key Statistics

Price/Earnings (Normalized)
28.43
Price/Sales
3.20
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
1.19%

Company Profile

Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and audio diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Growth
Total Number of Employees
21,623

Competitors

Valuation

Metric
DEMANT
GN
SOON
Price/Earnings (Normalized)
28.4326.7922.45
Price/Book Value
7.662.977.56
Price/Sales
3.201.604.39
Price/Cash Flow
16.5811.3520.77
Price/Earnings
DEMANT
GN
SOON

Financial Strength

Metric
DEMANT
GN
SOON
Quick Ratio
0.840.410.76
Current Ratio
1.370.591.29
Interest Coverage
6.913.9929.18
Quick Ratio
DEMANT
GN
SOON

Profitability

Metric
DEMANT
GN
SOON
Return on Assets (Normalized)
8.40%1.71%11.96%
Return on Equity (Normalized)
28.27%5.73%30.61%
Return on Invested Capital (Normalized)
12.19%3.07%22.85%
Return on Assets
DEMANT
GN
SOON
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesQcfjyspdrPxsjfck$182.3 Bil
SYK
Stryker CorpVtxfzrgrKqwj$123.6 Bil
MDT
Medtronic PLCCdsdrstbcYlmqx$110.9 Bil
BSX
Boston Scientific CorpMjbwjghPvrwpf$107.0 Bil
EW
Edwards Lifesciences CorpXgxdbhwdvgLxkhh$51.0 Bil
DXCM
DexCom IncZlrdprvlPdh$49.5 Bil
ZBH
Zimmer Biomet Holdings IncQxqhxlfxtPgfj$24.6 Bil
PHG
Koninklijke Philips NV ADRFwbtzdsGtgxwtv$24.3 Bil
ALGN
Align Technology IncZkpbtnvYzmqkt$20.5 Bil
PODD
Insulet CorpKrfkxlcyTsxkn$11.3 Bil

Sponsor Center